Free Trial
NASDAQ:EMBC

Embecta (EMBC) Stock Price, News & Analysis

Embecta logo
$14.62 +0.14 (+0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$14.62 0.00 (-0.03%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Embecta Stock (NASDAQ:EMBC)

Key Stats

Today's Range
$14.34
$14.82
50-Day Range
$9.28
$14.59
52-Week Range
$9.20
$21.48
Volume
405,487 shs
Average Volume
600,066 shs
Market Capitalization
$855.05 million
P/E Ratio
10.22
Dividend Yield
4.10%
Price Target
$19.00
Consensus Rating
Moderate Buy

Company Overview

Embecta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

EMBC MarketRank™: 

Embecta scored higher than 93% of companies evaluated by MarketBeat, and ranked 70th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Embecta has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Embecta has only been the subject of 2 research reports in the past 90 days.

  • Read more about Embecta's stock forecast and price target.
  • Earnings Growth

    Earnings for Embecta are expected to grow by 7.72% in the coming year, from $2.85 to $3.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Embecta is 10.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.29.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Embecta is 10.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.65.

  • Price to Earnings Growth Ratio

    Embecta has a PEG Ratio of 0.80. PEG Ratios below 1 indicate that a company could be undervalued.

  • Percentage of Shares Shorted

    5.47% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 4.50%, indicating that investor sentiment is improving.
  • Dividend Leadership

    Embecta is a leading dividend payer. It pays a dividend yield of 4.14%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Embecta does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Embecta is 41.96%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Embecta will have a dividend payout ratio of 19.54% next year. This indicates that Embecta will be able to sustain or increase its dividend.

  • Read more about Embecta's dividend.
  • Percentage of Shares Shorted

    5.47% of the float of Embecta has been sold short.
  • Short Interest Ratio / Days to Cover

    Embecta has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Embecta has recently decreased by 4.50%, indicating that investor sentiment is improving.
  • News Sentiment

    Embecta has a news sentiment score of 1.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.12 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Embecta this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for EMBC on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Embecta to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Embecta insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.42% of the stock of Embecta is held by insiders.

  • Percentage Held by Institutions

    93.83% of the stock of Embecta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Embecta's insider trading history.
Receive EMBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Embecta and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMBC Stock News Headlines

Upgrading Embecta Due To Reorganization And Growth Initiatives
Turn $1K into $50K with This DeFi Gem
Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.tc pixel
embecta to Participate in Investor Events
See More Headlines

EMBC Stock Analysis - Frequently Asked Questions

Embecta's stock was trading at $20.65 at the beginning of the year. Since then, EMBC shares have decreased by 29.2% and is now trading at $14.62.

Embecta Corp. (NASDAQ:EMBC) announced its earnings results on Friday, August, 8th. The company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.35. The firm's revenue for the quarter was up 8.4% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Embecta include American Century Companies Inc. (8.89%), River Road Asset Management LLC (5.54%), Yacktman Asset Management LP (4.06%) and William Blair Investment Management LLC (3.41%). Insiders that own company stock include Devdatt Kurdikar, David F Melcher, Jacob Elguicze, Jeffrey Z Mann and Milton Mayo Morris.
View institutional ownership trends
.

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Embecta investors own include Waste Connections (WCN), AU Optronics (AUOTY), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 6/13 Dividend
5/28/2025
Ex-Dividend for 6/13 Dividend
5/28/2025
Dividend Payable
6/13/2025
Last Earnings
8/08/2025
Record date for 9/15 Dividend
8/29/2025
Ex-Dividend for 9/15 Dividend
8/29/2025
Today
9/02/2025
Dividend Payable
9/15/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:EMBC
CIK
1872789
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$12.00
Potential Upside/Downside
+30.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.43
Trailing P/E Ratio
10.15
Forward P/E Ratio
5.10
P/E Growth
0.8
Net Income
$78.30 million
Net Margins
7.58%
Pretax Margin
9.10%
Return on Equity
-23.40%
Return on Assets
14.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.47
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$1.12 billion
Price / Sales
0.76
Cash Flow
$3.35 per share
Price / Cash Flow
4.34
Book Value
($12.80) per share
Price / Book
-1.13

Miscellaneous

Outstanding Shares
58,490,000
Free Float
58,239,000
Market Cap
$849.51 million
Optionable
Optionable
Beta
1.11
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:EMBC) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners